Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.03 USD
Change Today -0.0001 / -0.39%
Volume 969.8K
PSID On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

positiveid corp (PSID) Snapshot

Open
$0.03
Previous Close
$0.03
Day High
$0.03
Day Low
$0.03
52 Week High
03/31/14 - $0.11
52 Week Low
01/15/15 - $0.02
Market Cap
6.0M
Average Volume 10 Days
4.7M
EPS TTM
--
Shares Outstanding
235.5M
EX-Date
08/29/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for POSITIVEID CORP (PSID)

Related News

No related news articles were found.

positiveid corp (PSID) Related Businessweek News

View More BusinessWeek News

positiveid corp (PSID) Details

PositiveID Corporation develops biological detection and diagnostics systems for homeland defense and rapid biological testing. It has a portfolio of intellectual property related to sample preparation and rapid medical testing applications. The company’s M-BAND technology, developed under contract with the U.S. DHS Science & Technology directorate, is a bio-aerosol monitor with integrated systems for sample collection, processing, and detection modules. M-BAND technology analyzes air samples for the detection of pathogenic bacteria, viruses, and toxins for up to 30 days. The company’s Firefly Dx is a handheld, portable system designed to deliver molecular diagnostic results from a sample in less than 30 minutes at the point-of-need. Firefly is being developed for a range of biological detection situations, including radiation-induced cell damage within the human body and strains of influenza, and has demonstrated the ability to detect and identify other common pathogens and diseases, such as E. coli, methicillin-resistant staphylococcus aureus, and human papilloma virus. The company was formerly known as VeriChip Corporation and changed its name to PositiveID Corporation in November 2009. PositiveID Corporation was founded in 2001 and is headquartered in Delray Beach, Florida.

8 Employees
Last Reported Date: 04/11/14
Founded in 2001

positiveid corp (PSID) Top Compensated Officers

Chairman, Chief Executive Officer, Acting Chi...
Total Annual Compensation: $413.0K
Compensation as of Fiscal Year 2013.

positiveid corp (PSID) Key Developments

PositiveID Announces First Firefly Dx Testing and Delivery of Positive PCR Results Within 20 Minutes

PositiveID Corporation announced that it has successfully completed its first round of testing of its phase II Firefly Dx prototype handheld real-time PCR (polymerase chain reaction) pathogen detection system, and has delivered positive PCR results within 20 minutes. The company's Firefly Dx testing was performed at standard laboratory volumes and achieved equivalent results to laboratory-based PCR instruments, which can take hours to perform the same PCR process. The company previously announced it completed its Firefly Dx PCR design, and it has now completed successful testing on its Phase II breadboard Firefly Dx system, with consistent and repeated detection of each positive challenge. With the completion of the PCR chip design with confirmatory results, the Company is now in the next phase of testing to encompass optimization and a broader spectrum of tests. Firefly Dx is designed to provide real-time, accurate diagnostic results in a handheld device, thereby leading to treatment scenarios at the point of need that are not possible with existing systems, which require lab-based equipment and can take hours or even days to provide results. Firefly Dx is targeting the global PCR market, which is projected to reach approximately $27.4 billion this year.

PositiveID Corporation Achieves Firefly Dx Development Milestone With Completion of Breadboard PCR

PositiveID Corporation announced that it has achieved a significant milestone in the development of its handheld Firefly Dx system with the completion of the build of its breadboard PCR (polymerase chain reaction) chip. The company has begun testing assays to prove the design of achieving PCR results in less than 20 minutes at standard laboratory volumes, compared to existing technologies which require lab-based equipment and can take hours or days to provide results. The company plans to announce the results of its testing as it is completed over the next several months. PositiveID will run rapid thermal cycling with 40 PCR cycles of heating and cooling. Because the Firefly Dx system uses industry-standard 25 – 30 uL reaction volumes, the Company expects that existing FDA-cleared real-time PCR assays can be ported to the system rapidly, reducing development time and expense. As PositiveID's engineering and biology teams complete their evaluation of the updated sample preparation and PCR design to be integrated into the final iteration of the Firefly Dx cartridge, the Company will also complete optimization of the lyophilized PCR reagents with its reagent supplier. Once validation is complete, the designs will be integrated into an injection molded disposable cartridge, which will be evaluated and optimized to run automatically on the breadboard Firefly Dx platform. PositiveID is developing Firefly Dx based on intellectual property and know-how gained during years of development and $30 million of contract funding from the U.S. Department of Homeland Security for the company's M-BAND system, which uses PCR for the identification of airborne bio-threats. The Company has miniaturized its proven real-time PCR technology for the handheld Firefly Dx system, which is designed for use by first response teams to detect biological agents associated with weapons of mass destruction; agricultural screening in domestic sectors and developing countries; and point-of-need monitoring of pathogenic outbreaks. The Firefly Dx instrument will combine sample lysis, purification, real-time PCR analysis, electronic reporting of results, and automated chain of custody with the embedded RFID chip in disposable cartridges. The system is designed to automatically process and purify nucleic acids from diverse sample types, which are then analyzed with the incorporated multiplex PCR assay for multiple user-defined targets. Results can be immediately obtained and processed in-situ via SMART phone interface (or personal computer) with a specialized, mobile HTML application and Cloud-based data sharing and storage. The ease-of-use, portability, low cost, and assay flexibility is designed to provide the user with confidence and assurance of an analytically accurate response in limited and remote environments.

PositiveID Corporation Provides Earnings Guidance for the Fiscal 2015

PositiveID Corporation provided earnings guidance for the fiscal 2015. The company expects revenue of $3-6 million for 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PSID:US $0.03 USD -0.0001

PSID Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ALR Technologies Inc $0.0095 USD -0.0004
Medtronic PLC $77.38 USD +0.77
Microsoft Corp $40.97 USD -0.24
View Industry Companies
 

Industry Analysis

PSID

Industry Average

Valuation PSID Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact POSITIVEID CORP, please visit www.psidcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.